Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
“The downed timber from Hurricane Helene didn’t contribute to the ignition of the fires, but it is absolutely impacting firefighters’ access to the fire...”
“We oppose the port fees because they are going to have a severe effect on the U.S. economy and, in particular, agricultural exporters and farmers.”
